Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4212725015 | Genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation positive | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4212726019 | Genetic susceptibility to malignant hyperthermia due to RYR1 (ryanodine receptor 1) gene mutation positive | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4212727011 | Genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation positive (finding) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation positive | est un(e) (attribut) | Genetic susceptibility to malignant hyperthermia (finding) | true | Inferred relationship | Some | ||
| Genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation positive | a pour interprétation (attribut) | Positive | true | Inferred relationship | Some | 1 | |
| Genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation positive | interprète (attribut) | Genetic test (procedure) | true | Inferred relationship | Some | 1 | |
| Genetic susceptibility to malignant hyperthermia due to ryanodine receptor 1 gene mutation positive | est un(e) (attribut) | Positive genetic finding (finding) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR